While the impact of the IRA on the pharmaceutical industry cannot yet be fully determined, it is likely to be significant.
All entries for: Rhythm Pharmaceuticals
April 29, 2025
Rhythm Pharmaceuticals
Neutral Outlook
Boston, MA
201-500 employees
Disease Area: Endocrinology, Metabolic Diseases, Multiple, Rare Diseases
Drug Type: Small Molecule